91 results
Page 3 of 5
8-K
EX-10.1
pk1m4devq7pfoobtg8xl
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.1
xhpsckn
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
8-K
EX-1.1
4wf0x7a0fvh 1lh1v
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
7x11i46rj byfz6
5 Oct 20
Prospectus supplement with pricing info
4:16pm
DEF 14C
rgvobyw5k4ahdvd
27 May 20
Information statement
5:15pm
PRE 14C
nlmf1
15 May 20
Preliminary information
1:50pm
8-K
EX-99.1
8awtaeq00n
20 Dec 19
Processa Pharmaceuticals Announces 1 for 7 Reverse Stock Split of Its Common Stock
4:20pm
DEF 14C
jv7qko u28h1
25 Nov 19
Information statement
2:29pm